Cargando…
Regulatory T-cell therapy in Crohn’s disease: challenges and advances
The prevalence of IBD is rising in the Western world. Despite an increasing repertoire of therapeutic targets, a significant proportion of patients suffer chronic morbidity. Studies in mice and humans have highlighted the critical role of regulatory T cells in immune homeostasis, with defects in num...
Autores principales: | Clough, Jennie N, Omer, Omer S, Tasker, Scott, Lord, Graham M, Irving, Peter M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229901/ https://www.ncbi.nlm.nih.gov/pubmed/31980447 http://dx.doi.org/10.1136/gutjnl-2019-319850 |
Ejemplares similares
-
Advancing human gut microbiota research by considering gut transit time
por: Procházková, Nicola, et al.
Publicado: (2023) -
Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells
por: Powell, Nick, et al.
Publicado: (2020) -
Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
por: Ting, Nick Lung-Ngai, et al.
Publicado: (2022) -
A Crohn’s Disease-associated IL2RA Enhancer Variant Determines the Balance of T Cell Immunity by Regulating Responsiveness to IL-2 Signalling
por: Goldberg, Rimma, et al.
Publicado: (2021) -
MicroRNAs: new players in IBD
por: Kalla, R, et al.
Publicado: (2015)